UniProt ID | FUBP1_HUMAN | |
---|---|---|
UniProt AC | Q96AE4 | |
Protein Name | Far upstream element-binding protein 1 | |
Gene Name | FUBP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 644 | |
Subcellular Localization | Nucleus . | |
Protein Description | Regulates MYC expression by binding to a single-stranded far-upstream element (FUSE) upstream of the MYC promoter. May act both as activator and repressor of transcription.. | |
Protein Sequence | MADYSTVPPPSSGSAGGGGGGGGGGGVNDAFKDALQRARQIAAKIGGDAGTSLNSNDYGYGGQKRPLEDGDQPDAKKVAPQNDSFGTQLPPMHQQQSRSVMTEEYKVPDGMVGFIIGRGGEQISRIQQESGCKIQIAPDSGGLPERSCMLTGTPESVQSAKRLLDQIVEKGRPAPGFHHGDGPGNAVQEIMIPASKAGLVIGKGGETIKQLQERAGVKMVMIQDGPQNTGADKPLRITGDPYKVQQAKEMVLELIRDQGGFREVRNEYGSRIGGNEGIDVPIPRFAVGIVIGRNGEMIKKIQNDAGVRIQFKPDDGTTPERIAQITGPPDRCQHAAEIITDLLRSVQAGNPGGPGPGGRGRGRGQGNWNMGPPGGLQEFNFIVPTGKTGLIIGKGGETIKSISQQSGARIELQRNPPPNADPNMKLFTIRGTPQQIDYARQLIEEKIGGPVNPLGPPVPHGPHGVPGPHGPPGPPGPGTPMGPYNPAPYNPGPPGPAPHGPPAPYAPQGWGNAYPHWQQQAPPDPAKAGTDPNSAAWAAYYAHYYQQQAQPPPAAPAGAPTTTQTNGQGDQQNPAPAGQVDYTKAWEEYYKKMGQAVPAPTGAPPGGQPDYSAAWAEYYRQQAAYYAQTSPQGMPQHPPAPQGQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MADYSTVPP ------CCCCCCCCC | 25.17 | 19413330 | |
4 | Phosphorylation | ----MADYSTVPPPS ----CCCCCCCCCCC | 9.19 | 18491316 | |
5 | Phosphorylation | ---MADYSTVPPPSS ---CCCCCCCCCCCC | 24.39 | 27251275 | |
6 | Phosphorylation | --MADYSTVPPPSSG --CCCCCCCCCCCCC | 30.70 | 27251275 | |
11 | Phosphorylation | YSTVPPPSSGSAGGG CCCCCCCCCCCCCCC | 53.78 | 25159151 | |
12 | Phosphorylation | STVPPPSSGSAGGGG CCCCCCCCCCCCCCC | 42.41 | 25159151 | |
14 | Phosphorylation | VPPPSSGSAGGGGGG CCCCCCCCCCCCCCC | 26.20 | 25159151 | |
32 | Ubiquitination | GGVNDAFKDALQRAR CHHHHHHHHHHHHHH | 43.76 | - | |
44 | Acetylation | RARQIAAKIGGDAGT HHHHHHHHHCCCCCC | 32.63 | 23954790 | |
44 | Ubiquitination | RARQIAAKIGGDAGT HHHHHHHHHCCCCCC | 32.63 | 21906983 | |
44 (in isoform 1) | Ubiquitination | - | 32.63 | 21890473 | |
44 (in isoform 2) | Ubiquitination | - | 32.63 | 21890473 | |
51 | Phosphorylation | KIGGDAGTSLNSNDY HHCCCCCCCCCCCCC | 31.59 | 21945579 | |
52 | Phosphorylation | IGGDAGTSLNSNDYG HCCCCCCCCCCCCCC | 25.33 | 21945579 | |
55 | Phosphorylation | DAGTSLNSNDYGYGG CCCCCCCCCCCCCCC | 36.05 | 21945579 | |
58 | Phosphorylation | TSLNSNDYGYGGQKR CCCCCCCCCCCCCCC | 19.25 | 21945579 | |
60 | Phosphorylation | LNSNDYGYGGQKRPL CCCCCCCCCCCCCCC | 16.32 | 21945579 | |
64 | Acetylation | DYGYGGQKRPLEDGD CCCCCCCCCCCCCCC | 60.29 | 26051181 | |
64 | Ubiquitination | DYGYGGQKRPLEDGD CCCCCCCCCCCCCCC | 60.29 | 21906983 | |
64 (in isoform 1) | Ubiquitination | - | 60.29 | 21890473 | |
64 (in isoform 2) | Ubiquitination | - | 60.29 | 21890473 | |
76 | Acetylation | DGDQPDAKKVAPQND CCCCCCHHHCCCCCC | 55.98 | 25953088 | |
76 | Ubiquitination | DGDQPDAKKVAPQND CCCCCCHHHCCCCCC | 55.98 | 21906983 | |
76 (in isoform 1) | Ubiquitination | - | 55.98 | 21890473 | |
76 (in isoform 2) | Ubiquitination | - | 55.98 | 21890473 | |
77 | Acetylation | GDQPDAKKVAPQNDS CCCCCHHHCCCCCCC | 45.40 | 7378677 | |
77 | Ubiquitination | GDQPDAKKVAPQNDS CCCCCHHHCCCCCCC | 45.40 | - | |
84 | Phosphorylation | KVAPQNDSFGTQLPP HCCCCCCCCCCCCCC | 32.88 | 20068231 | |
84 (in isoform 2) | Phosphorylation | - | 32.88 | 28674419 | |
87 | Phosphorylation | PQNDSFGTQLPPMHQ CCCCCCCCCCCCHHH | 25.56 | 20068231 | |
87 (in isoform 2) | Phosphorylation | - | 25.56 | 20068231 | |
98 (in isoform 2) | Phosphorylation | - | 29.00 | 21857030 | |
99 | Phosphorylation | MHQQQSRSVMTEEYK HHHHHCCCCCCCEEC | 22.84 | 23911959 | |
102 | Phosphorylation | QQSRSVMTEEYKVPD HHCCCCCCCEECCCC | 24.41 | 28450419 | |
105 | Phosphorylation | RSVMTEEYKVPDGMV CCCCCCEECCCCCCE | 15.85 | 21406692 | |
118 | Methylation | MVGFIIGRGGEQISR CEEEEECCCCHHHHH | 39.26 | - | |
133 | Acetylation | IQQESGCKIQIAPDS HHHHHCCEEEECCCC | 40.97 | 25953088 | |
133 | Ubiquitination | IQQESGCKIQIAPDS HHHHHCCEEEECCCC | 40.97 | - | |
140 | Phosphorylation | KIQIAPDSGGLPERS EEEECCCCCCCCCCC | 33.43 | 30266825 | |
147 | Phosphorylation | SGGLPERSCMLTGTP CCCCCCCCEECCCCH | 11.39 | 23403867 | |
148 | Glutathionylation | GGLPERSCMLTGTPE CCCCCCCEECCCCHH | 3.03 | 22555962 | |
148 | S-nitrosylation | GGLPERSCMLTGTPE CCCCCCCEECCCCHH | 3.03 | 22126794 | |
149 | Sulfoxidation | GLPERSCMLTGTPES CCCCCCEECCCCHHH | 3.86 | 21406390 | |
151 | Phosphorylation | PERSCMLTGTPESVQ CCCCEECCCCHHHHH | 16.48 | 30266825 | |
153 | Phosphorylation | RSCMLTGTPESVQSA CCEECCCCHHHHHHH | 20.74 | 22167270 | |
156 | Phosphorylation | MLTGTPESVQSAKRL ECCCCHHHHHHHHHH | 27.02 | 30266825 | |
159 | Phosphorylation | GTPESVQSAKRLLDQ CCHHHHHHHHHHHHH | 33.33 | 23927012 | |
161 | Acetylation | PESVQSAKRLLDQIV HHHHHHHHHHHHHHH | 49.15 | 25953088 | |
161 | Ubiquitination | PESVQSAKRLLDQIV HHHHHHHHHHHHHHH | 49.15 | - | |
170 | Acetylation | LLDQIVEKGRPAPGF HHHHHHHCCCCCCCC | 49.69 | 25953088 | |
196 | Acetylation | EIMIPASKAGLVIGK EEEEEHHHCCEEECC | 48.88 | 25953088 | |
202 (in isoform 2) | Ubiquitination | - | 18.31 | 21890473 | |
203 | Ubiquitination | KAGLVIGKGGETIKQ HCCEEECCCCHHHHH | 53.25 | 21906983 | |
203 (in isoform 1) | Ubiquitination | - | 53.25 | 21890473 | |
207 | Phosphorylation | VIGKGGETIKQLQER EECCCCHHHHHHHHH | 36.43 | 22817900 | |
208 (in isoform 2) | Ubiquitination | - | 2.02 | 21890473 | |
209 | Ubiquitination | GKGGETIKQLQERAG CCCCHHHHHHHHHHC | 52.99 | - | |
209 (in isoform 1) | Ubiquitination | - | 52.99 | 21890473 | |
218 | Acetylation | LQERAGVKMVMIQDG HHHHHCCCEEEEECC | 25.51 | 25953088 | |
218 | Ubiquitination | LQERAGVKMVMIQDG HHHHHCCCEEEEECC | 25.51 | - | |
219 | Sulfoxidation | QERAGVKMVMIQDGP HHHHCCCEEEEECCC | 1.99 | 28183972 | |
221 | Sulfoxidation | RAGVKMVMIQDGPQN HHCCCEEEEECCCCC | 1.72 | 28183972 | |
229 | Phosphorylation | IQDGPQNTGADKPLR EECCCCCCCCCCCCE | 28.62 | 20068231 | |
233 | Acetylation | PQNTGADKPLRITGD CCCCCCCCCCEECCC | 45.47 | 26051181 | |
242 | Phosphorylation | LRITGDPYKVQQAKE CEECCCCHHHHHHHH | 28.65 | 28152594 | |
243 | Acetylation | RITGDPYKVQQAKEM EECCCCHHHHHHHHH | 38.67 | 23749302 | |
243 | Malonylation | RITGDPYKVQQAKEM EECCCCHHHHHHHHH | 38.67 | 26320211 | |
243 | Ubiquitination | RITGDPYKVQQAKEM EECCCCHHHHHHHHH | 38.67 | - | |
250 | Sulfoxidation | KVQQAKEMVLELIRD HHHHHHHHHHHHHHH | 4.03 | 28183972 | |
268 | Phosphorylation | FREVRNEYGSRIGGN HHHHHHHHHCCCCCC | 24.77 | 30576142 | |
270 | Phosphorylation | EVRNEYGSRIGGNEG HHHHHHHCCCCCCCC | 21.59 | 21712546 | |
300 | Ubiquitination | RNGEMIKKIQNDAGV CCHHHHHHHCCCCCC | 38.30 | - | |
308 | Methylation | IQNDAGVRIQFKPDD HCCCCCCCEEECCCC | 18.97 | - | |
311 (in isoform 2) | Ubiquitination | - | 13.27 | 21890473 | |
312 | Sumoylation | AGVRIQFKPDDGTTP CCCCEEECCCCCCCH | 31.03 | - | |
312 | Acetylation | AGVRIQFKPDDGTTP CCCCEEECCCCCCCH | 31.03 | 23954790 | |
312 | Malonylation | AGVRIQFKPDDGTTP CCCCEEECCCCCCCH | 31.03 | 26320211 | |
312 | Sumoylation | AGVRIQFKPDDGTTP CCCCEEECCCCCCCH | 31.03 | - | |
312 | Ubiquitination | AGVRIQFKPDDGTTP CCCCEEECCCCCCCH | 31.03 | - | |
312 (in isoform 1) | Ubiquitination | - | 31.03 | 21890473 | |
317 | Phosphorylation | QFKPDDGTTPERIAQ EECCCCCCCHHHHHH | 46.29 | 29214152 | |
318 | Phosphorylation | FKPDDGTTPERIAQI ECCCCCCCHHHHHHH | 28.78 | 28674419 | |
321 | Methylation | DDGTTPERIAQITGP CCCCCHHHHHHHHCC | 30.65 | - | |
331 | Methylation | QITGPPDRCQHAAEI HHHCCCHHHHHHHHH | 27.98 | - | |
359 | Dimethylation | GGPGPGGRGRGRGQG CCCCCCCCCCCCCCC | 37.23 | - | |
359 | Methylation | GGPGPGGRGRGRGQG CCCCCCCCCCCCCCC | 37.23 | 24129315 | |
361 | Dimethylation | PGPGGRGRGRGQGNW CCCCCCCCCCCCCCC | 30.21 | - | |
361 | Methylation | PGPGGRGRGRGQGNW CCCCCCCCCCCCCCC | 30.21 | 24129315 | |
363 | Dimethylation | PGGRGRGRGQGNWNM CCCCCCCCCCCCCCC | 32.66 | - | |
363 | Methylation | PGGRGRGRGQGNWNM CCCCCCCCCCCCCCC | 32.66 | 24129315 | |
394 | Acetylation | KTGLIIGKGGETIKS CCEEEECCCCHHHHH | 54.02 | 25953088 | |
394 | Malonylation | KTGLIIGKGGETIKS CCEEEECCCCHHHHH | 54.02 | 26320211 | |
394 | Succinylation | KTGLIIGKGGETIKS CCEEEECCCCHHHHH | 54.02 | 23954790 | |
394 | Ubiquitination | KTGLIIGKGGETIKS CCEEEECCCCHHHHH | 54.02 | - | |
398 | Phosphorylation | IIGKGGETIKSISQQ EECCCCHHHHHHHHH | 36.66 | - | |
399 (in isoform 2) | Ubiquitination | - | 2.61 | 21890473 | |
400 | Acetylation | GKGGETIKSISQQSG CCCCHHHHHHHHHCC | 49.51 | 23236377 | |
400 | Ubiquitination | GKGGETIKSISQQSG CCCCHHHHHHHHHCC | 49.51 | 21906983 | |
400 (in isoform 1) | Ubiquitination | - | 49.51 | 21890473 | |
424 (in isoform 2) | Ubiquitination | - | 4.93 | 21890473 | |
425 | Acetylation | PNADPNMKLFTIRGT CCCCCCCEEEEECCC | 47.27 | 23236377 | |
425 | Ubiquitination | PNADPNMKLFTIRGT CCCCCCCEEEEECCC | 47.27 | 2189047 | |
425 (in isoform 1) | Ubiquitination | - | 47.27 | 21890473 | |
428 | Phosphorylation | DPNMKLFTIRGTPQQ CCCCEEEEECCCHHH | 21.87 | 29214152 | |
430 | Methylation | NMKLFTIRGTPQQID CCEEEEECCCHHHHH | 39.62 | - | |
432 | Phosphorylation | KLFTIRGTPQQIDYA EEEEECCCHHHHHHH | 14.21 | 25159151 | |
438 | Nitration | GTPQQIDYARQLIEE CCHHHHHHHHHHHHH | 12.81 | - | |
438 | Phosphorylation | GTPQQIDYARQLIEE CCHHHHHHHHHHHHH | 12.81 | 28152594 | |
446 | Ubiquitination | ARQLIEEKIGGPVNP HHHHHHHHHCCCCCC | 33.58 | - | |
589 | Phosphorylation | YTKAWEEYYKKMGQA HHHHHHHHHHHHCCC | 14.74 | 28152594 | |
590 | Phosphorylation | TKAWEEYYKKMGQAV HHHHHHHHHHHCCCC | 13.86 | 28152594 | |
591 | Acetylation | KAWEEYYKKMGQAVP HHHHHHHHHHCCCCC | 35.07 | 23749302 | |
591 | Succinylation | KAWEEYYKKMGQAVP HHHHHHHHHHCCCCC | 35.07 | 23954790 | |
592 | Ubiquitination | AWEEYYKKMGQAVPA HHHHHHHHHCCCCCC | 31.94 | - | |
601 | O-linked_Glycosylation | GQAVPAPTGAPPGGQ CCCCCCCCCCCCCCC | 48.35 | 32119511 | |
601 | Phosphorylation | GQAVPAPTGAPPGGQ CCCCCCCCCCCCCCC | 48.35 | 21945579 | |
611 | Phosphorylation | PPGGQPDYSAAWAEY CCCCCCCCHHHHHHH | 13.59 | 21945579 | |
612 | Phosphorylation | PGGQPDYSAAWAEYY CCCCCCCHHHHHHHH | 20.91 | 21945579 | |
618 | Phosphorylation | YSAAWAEYYRQQAAY CHHHHHHHHHHHHHH | 9.01 | - | |
619 | Phosphorylation | SAAWAEYYRQQAAYY HHHHHHHHHHHHHHH | 8.08 | - | |
625 | Phosphorylation | YYRQQAAYYAQTSPQ HHHHHHHHHHCCCCC | 11.44 | 21945579 | |
626 | Phosphorylation | YRQQAAYYAQTSPQG HHHHHHHHHCCCCCC | 6.36 | 21945579 | |
629 | Phosphorylation | QAAYYAQTSPQGMPQ HHHHHHCCCCCCCCC | 33.91 | 26846344 | |
630 | Phosphorylation | AAYYAQTSPQGMPQH HHHHHCCCCCCCCCC | 11.80 | 26846344 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
58 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
268 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
625 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | PRKN | O60260 | PMID:16672220 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FUBP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FUBP1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-52; SER-55; THR-153 AND SER-630, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-630, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-52; SER-55; THR-153 AND SER-630, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140; THR-153 ANDSER-630, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-153 AND SER-630, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-153, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-626, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-58, AND MASSSPECTROMETRY. |